Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
ABLBio (298380 KS)
Watchlist
41
Analysis
Health Care
•
South Korea
ABLBio, Inc. operates as a drugs development company. The Company develops and manufactures neurodegenerative diseases therapeutic drugs, oncology therapeutic drugs, and other products. ABLBio markets its products throughout Korea.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Zijin Gold International
•
19 Feb 2026 05:50
Asia Pac: (Forecast) Global Index Changes in March as Adds Outperform Bigly
There will be over 250 changes in AP for a global index in March. The large adds have outperformed their country indices over the last few months...
Brian Freitas
Follow
421 Views
Share
bearish
•
Quantitative Analysis
•
09 Feb 2026 07:05
KRX Foreign Holding Weekly (Feb 6th): Samsung Electronics, SK Hynix, Hyundai Motor, SKSQUARE
We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Samsung Electronics, SK Hynix, Hyundai Motor,...
Ke Yan, CFA, FRM
Follow
341 Views
Share
bullish
•
Quantitative Analysis
•
02 Feb 2026 07:05
KRX Foreign Holding Weekly (Jan 30th): Hyundai Motor, Samsung Electronics, SK Hynix, NAVER
We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Hyundai Motor, Samsung Electronics, SK Hynix,...
Ke Yan, CFA, FRM
Follow
263 Views
Share
bearish
•
SK Innovation
•
07 Jan 2026 05:30
KRX New Deal Index Rebalance Preview: Chunky Flows in Some Stocks
There will be multiple changes for the New Deal indices in March. The largest flows will be in Samsung SDI and SK Innovation.
Brian Freitas
Follow
727 Views
Share
bullish
•
Quantitative Analysis
•
05 Jan 2026 07:05
KRX Foreign Holding Weekly (Jan 2nd): SK Hynix, Samsung Electronics, LG Energy Solution, Kakao
We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in SK Hynix, Samsung Electronics, LG Energy...
Ke Yan, CFA, FRM
Follow
344 Views
Share
First
Previous
2
3
4
5
6
7
8
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x